• Home
  • Investors
  • Corporate Governance
  • Board Structure

Board Structure

Composition of the BOD

The board of directors is composed of five members consisting of two internal directors and three indep endent directors. Independent directors are independent having no ties to the company through transactions or as former employees or inside directors.

  • President & CEO - Dr. Tae Han Kim
    President & CEO
    Dr. Tae Han Kim
    • President & CEO,
      Samsung Biologics
      (2011-Present)
    • Full Member,
      The National Academy of
      Engineering of Korea
      (2013-Present)
    President & CEO / Dr. Tae Han Kim
  • Senior Vice President & Managing Director / Dong joong Kim
    Senior Vice President
    & Managing Director
    Dong joong Kim
    • Senior Vice President & Managing
      Director, Business Resources Innovation Center, Samsung Biologics
      (2014-Present)
    • Head of Planning Support Team,
      Production Technology Institute,
      Samsung Electronics
      (2013-2014)
    Senior Vice President & Managing Director / Dong joong Kim
  • Independent director / Kun Nyoung Huh
    Independent Director
    Kun Nyoung Huh
    • Independent Director,
      Samsung Biologics
      (2019-Present)
    • Advisor, Pyeong An Lawfirm(2019-Present)
    • Presiding Judge,
      Seoul Central District Court
      (2004-2007)
    Independent director /
  • Independent director / Seok Woo Jeong
    Independent director
    Seok Woo Jeong
    • Independent Director,
      Samsung Biologics
      (2016-Present)
    • Professor, Department of Business Administration, Korea University Business School (1997-Present)
    • Non-standing Member,
      Korea Accounting Institute
      (2016-Present)
    Independent director / Seok Woo Jeong
  • Independent director / Soon Jo Kwon
    Independent director
    Soon Jo Kwon
    • Independent Director,
      Samsung Biologics
      (2016-Present)
    • Professor, Department of BioLogical Engineering, Inha University(2013-Present)
    • Chairman, International
      Cooperation Committee, Institute of Biological Engineering (IBE)
      (2011-2013)
    Independent director / Soon Jo Kwon

Appointment of Directors

Members of the board of directors are elected through a resolution of the general meeting of shareholders under the company’s articles of incorporation. Incumbent members may be reelected after the expiration of their terms.

  • Samsung Biologics shall have at least three but no more than ten directors and such directors shall be appointed at the general meeting of shareholders; provided, however, that at least three independent directors shall be appointed and the number of the independent directors shall account for at last a majority of the total number of directors.
  • A resolution for the election of directors shall be adopted by the affirmative votes of a majority of the shareholders present at the meeting, which shall also be at least 1/4 of the total number of issued and outstanding shares.
  • Any vacancy in the office of directors shall be filled at a general meeting of shareholders; provided, however, that if the number of directors does not fall below the number prescribed in Paragraph 1 of Article 29 in the Articles of Incorporation and there is no difficulty in the administration of business, the foregoing shall not be applicable.

Term of Office of Director

The term of office of directors shall end at the close of the ordinary general meeting of shareholders convened in respect to the last fiscal year within three years from their appointment.

Chairperson

The chairperson of the board of directors shall be appointed among the directors by a resolution of the board of directors.

Resolution of the BOD

The resolution of the board of directors shall be adopted in the attendance of a majority of the directors in the office and by the affirmative votes of a majority of the directors present at the meeting; provided, however, that a resolution of the board of directors on matters stipulated under Article 397-2 (Prohibition of Use of Corporate Opportunities and Assets) and Article 398 (Self-Dealing between Directors, etc. and the Company) of the Commercial Code shall be adopted by the affirmative votes of at least 2/3 of the directors in office.

Independence of Independent Directors

The Independent Director Candidate Nomination Committee shall nominate the candidates for the independent directors among persons who meet qualification requirements stipulated in the relevant laws and regulations, including the Commercial Code, etc.

  • An independent director shall be one with professional knowledge or sufficient experience in management, economics, accounting, law or relevant technology and duly qualified under the relevant law. He or she shall not be a current employee or director or a previous employee or director of the company or its affiliate (as stipulated in the Monopoly Regulation and Fair Trade Act) within the past two years, a major shareholder of the company or one with a special relationship with a major shareholder.

Operation / Duties

The board of directors shall be divided into an ordinary and extraordinary board.
In principle the chairperson convenes the board of directors meeting, and if it is deemed necessary for administration of business, any director may convene the board of directors meeting with the consent of the chairperson.

BOD Operation Rules PDF Download PDF doesn't open in Chrome

Meetings of the BOD

The board of directors shall be divided into an ordinary and extraordinary board.

  • Ordinary Board of Directors : The meeting of ordinary board of directors is held once a quarter. The chairperson of the board of directors shall set the date and call for the meeting.
  • Extraordinary Board of Directors : The meeting of extraordinary board of directors may be held from time to time as required.

Convening of BOD Meeting

In principle the chairperson convenes the board of directors meeting, and if it is deemed necessary for administration of business, any director may convene the board of directors meeting with the consent of the chairperson.

  • Procedure : The chairperson shall set a date and time of the meeting of the board of directors and give a notice to each director no later than twenty four hours prior to the meeting in writing, electronic document, or orally; provided, however, that such notice may be waived with the unanimous consent of all directors.

Resolution of the BOD

The resolution of the board of directors shall be adopted in the attendance of a majority of the directors in office and by the affirmative votes of a majority of the directors present at the meeting.

  • The board of directors may allow all or a part of the directors who do not attend a meeting in person to participate in a resolution through communication that concurrently transmits and receives voices of all directors. In this case, such director shall be deemed to have attended the board of directors meeting in person.
  • A director with his or her own interests in a resolution of the board of directors shall not be allowed to participate in voting.

BOD Operation Rules

Article 1Purpose
Article 2Scope of Applications
  • With respect to matters pertaining to the BOD, these rules and regulations shall apply unless those stipulated otherwise in the relevant laws or the AOI.
Article 3Authority
  • The BOD shall deliberate and resolve matters stipulated in the relevant laws or the AOI, matters authorized by the general meeting of shareholders, and important issues concerning basic policies and execution of business related to the management of the Company.
  • The BOD shall supervise the directors’ execution of duty.
  • When it is determined that a director has violated a provision of the laws or the AOI in performing his/her duties, or performed such duties in a substantially improper manner, or the BOD recognizes that there is a concern that such director will perform his/ her duties in a substantially improper manner, the BOD may request such director to submit relevant data, cooperate on investigation, and/or provide explanation.
  • If any of the events in Paragraph 3 occurs, the BOD may require the relevant director to suspend or change the performance of relevant duties.
  • Any director may request the representative director to report performance of other directors or employees to the BOD.
Article 4Composition
  • The BOD shall be comprised of all directors.
  • The term of office of a director shall expire at the close of the ordinary general meeting of shareholders held for the third fiscal period from the inauguration of the applicable director.
Article 5Chairperson
  • The chairperson of the BOD shall be appointed among the directors by a resolution of the BOD.
  • The term of office of the chairperson shall end at the expiration of the term of office of the applicable director.
  • When the chairperson is unable to perform his/her duties, the director that was first appointed among all of the directors of the BOD shall act as the chairperson; provided, however, that if two (2) or more directors were appointed on the same date, the most senior director shall act as the chairperson.
Article 6Convening of BOD Meeting
  • The meetings of the BOD shall be either ordinary meetings or extraordinary meetings.
  • Ordinary meetings of the BOD shall, in principle, be convened once each quarter.
  • Extraordinary meetings of the BOD shall be convened on an ad-hoc basis when deemed necessary.
  • The chairperson of the BOD shall set a date and time of the meeting of the BOD, and provide written, electronic, or oral notice to each director no later than 24 hours in advance of such meeting; provided, however, that such convocation procedure may be omitted upon unanimous consent of the directors.
  • If it is deemed necessary for carrying out the business of the Company, any director may convene a meeting of the BOD upon the consent of the chairperson. In this case, the provisions in Paragraph 4 above shall apply mutatis mutandis.
Article 7Method of Resolution
  • Unless stipulated otherwise in the relevant laws and regulations, the BOD resolutions shall be done in accordance with Paragraphs 1 through 3 of Article 38 of the AOI.
  • Unless stipulated otherwise in the relevant laws and regulations, the number of directors who cannot exercise his/her vote in accordance with Article 38, Paragraph 3 of the AOI shall not be included in the number of directors present at the meeting.
Article 8Agenda
  • The following matters shall be resolved by the BOD:
    • 1.Convening of the general meeting of shareholders and matters for resolution to be submitted thereto
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Convening of the general meeting of shareholders
      • 2)Approval of financial statements
      • 3)Approval of annual report
      • 4)Distribution of profits
      • 5)Amendment to the AOI
      • 6)Capital reduction
      • 7)Dissolution, amalgamation, spin-off, merger through spin-off, continuation of company (Article 519 of the Commercial Code)
      • 8)Assignment of the businesses of the Company in whole or in material part; acquisition in whole or in part of another company’s business having a material impact on the business of the Company
      • 9)Lease or entrustment of management business in whole; execution of contract where all profits and losses are shared with a 3rd party (each a “Shared Contract”); execution, amendment, or termination of another contract that is commensurate to a Shared Contract
      • 10)Ex-post incorporation
      • 11)Appointment and dismissal of directors
      • 12)Remuneration of directors
      • 13)Issuance of shares at less-than-face value
      • 14)Acquisition of treasury shares
      • 15)Decision on stock dividends
      • 16)Stock-split and stock-consolidation of shares
      • 17)Waiver of a director’s liability toward the Company upon unanimous consent of the shareholders
      • 18)Redemption of shares
      • 19)Total share swap
      • 20)Total share transfer
      • 21)Granting of stock options
      • 22)Other agenda items to be submitted to the general meeting of shareholders and material issues concerning shares
    • 2.Matters pertaining to management
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Decision on short form merger, short form merger through spin-off, small-scale mergers, and small-scale merger through spin-off
      • 2)Execution and reporting of asset revaluation
      【Other important matters pertaining to the management of the Company】
      • 1)Establishment and revision of basic policies on the management of the Company
    • 3.Matters pertaining to finance
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Disposition or redemption of treasury shares
      • 2)Issuance of new shares
      • 3)Issuance of corporate bonds, convertible bonds, or bonds with warrants
      • 4)Capitalization of reserves
      • 5)Allocation of new shares to a 3rd party
      • 6)Distribution of interim dividends
      • 7)Transaction with a “specially-related party” as set forth in the Commercial Code or large-scale transaction for a “specially-related party”
      • 8)Handling of forfeited shares in case of capitalization by issuing new shares
      【Other important matters pertaining to finance】
      • 1)Foreign direct investment valued at 2.5% or more of the equity capital of the Company
      • 2)Listing of shares or depository certificates in a foreign stock exchange
      • 3)Borrowing valued at 2.5% or more of the equity capital of the Company
      • 4)Acquisition or waiver of debt valued at 2.5% or more of the equity capital of the Company per transaction
      • 5)Offering of security or guarantee of debt valued at 2.5% or more of the equity capital of the Company per transaction
      • 6)Donation or sponsorship valued at KRW 100 million or more
      • 7)Other important financial matters to be submitted to the BOD
    • 4.Matters pertaining to directors, the BOD, committees, etc.
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Appointment of the representative director
      • 2)Appointment of the chairperson of the BOD in case the representative director is unable to serve as the chairperson
      • 3)Establishment and operation of a committee(s) within the BOD, appointment and dismissal of a committee member
      • 4)Approval of a director serving as a concurrent director at another company that competes with or operates in the same industry as the Company and approval of transaction between a director, etc., and the Company
      • 5)Re-resolution of an agenda item for resolution by a committee within the BOD
      • 6)Appointment or dismissal of a director from a specific position or duty
      【Other important matters pertaining to directors, the BOD, committees, etc.】
      • 1)Enforcement or nullification of the Rules and Regulations of the Board of Directors or the rules and regulations of committees within the BOD (operational guidelines)
    • 5.Others
      • 1)Other matters set forth in the relevant laws and regulations or the AOI, authorized and delegated by the general meeting of shareholders, or deemed necessary by the representative director
  • The following matters shall be reported to the BOD:
    • 1.Matters that have been delegated to a committee(s) within the BOD and how such matters were decided / resolved
    • 2.Matters for which the Audit Committee has determined that a director has or there is a concern that a director may violate the relevant laws or the AOI
    • 3.Other matters pertaining to the execution of matters that are considered important to the operations of the Company
Article 9Delegation of Authority
  • Unless stipulated otherwise in the relevant laws and regulations or the AOI, the representative director or a committee authorized by the BOD under Article 10 may be delegated with the authority to make decisions on matters that require a resolution of the BOD.
Article 10Committees under BOD
  • Committees within the BOD shall be subject to Article 37 of the AOI; provided, however, that with respect to the Audit Committee, Chapter 6 (Audit Committee) of the AOI shall first apply.
  • The Management Committee shall operate in compliance with the rules and resolutions of the BOD, and in addition, deliberate on and resolve matters delegated by the BOD from time to time.
  • Unless they are in conflict with Paragraph 1 of this Article 10 and the rules of applicable committee within the BOD, Article 38 of the AOI shall apply mutatis mutandis to the committee(s) within the BOD. In such provisions of the AOI, “BOD” shall mean applicable “committee within the BOD” and “Director” shall mean a “member of such committee.”
  • Notwithstanding anything stated in Paragraph 3 of Article 10, matters set forth in Article 397-2 (Restriction on Abuse of Corporate Opportunities and Assets of the Company) and Article 398 (Transactions between Directors, Etc., and the Company) of the Commercial Code shall be adopted by two-thirds or more of the registered directors of the BOD.
Article 11Counsel of Relevant Persons
  • In deliberating on an agenda item, the BOD may invite a relevant officer or employee of the Company or a third party to attend the BOD meeting and explain the agenda item or provide his/her opinion.
  • The BOD may, at the cost of the Company, resolve to engage an expert or other similar individual to consult on a particular agenda item, if it finds such a service necessary.
Article 12Meeting Minutes
  • Meeting minutes shall be prepared for BOD meetings and meetings of any committee within the BOD, and such meeting minutes shall set forth the agenda, proceedings of the meeting, results, objecting party and reason(s) for objection, and be affixed with the seal impressions of or signed by the directors present at the meeting.
Article 13Ratification
  • If an issue is urgent, and there is insufficient time to convene a meeting of the BOD, so long as and to the extent it does not violate the relevant laws and regulations, the representative director shall perform the necessary action and convene a meeting of the BOD after the fact where he/she shall report the progress of such action and obtain the BOD’s ratification.
Article 14Secretary
  • The BOD shall have a secretary who shall be appointed by the chairperson.
  • The chairperson of the BOD shall instruct and supervise the secretary. The secretary shall assist each director of the BOD and administer the overall operations of the BOD.
Article 15Expenses
  • Expenses necessary for meetings and other operations shall be borne by the Company.
Article 16Enactment and Nullification of the Rules
  • These Rules shall be enacted and nullified by a resolution of the BOD.
Addendum
  • Article 1 (Effective Date)
  • These Rules shall become effective on August 10, 2016.

Major Agenda items

1. A director with his or her own interests in a resolution of the board of directors shall not be allowed to participate in voting.

  • Convening of the general meeting of shareholders
  • Approval of financial statements
  • Approval of annual report
  • Amendment to the AOI
  • Dissolution, amalgamation, continuation of company
  • Assignment of the businesses of the company in whole or in material part; acquisition in whole or in part of another company’s business having a material impact on the business of the company.
  • Appointment and dismissal of directors
  • Remuneration of directors, etc.

2. Matters pertaining to management

  • Matters pertaining to management
  • Enforcement or nullification of the Rules and Regulations of the Board of Directors or the rules and regulations of committees within the BOD

3. Matters pertaining to finance

  • Disposition or redemption of treasury shares
  • issuance of new shares
  • Issuance of corporate bonds, convertible bonds, or bonds with warrants
  • Foreign direct investment, borrowing, acquisition or waiver of debt, offering of security or guarantee of debt, etc.
  • Transaction with a “specially-related party” as set forth in the Commercial Code or large-scale transaction for a “specially-related party”, etc.
  • Donation or sponsorship

4. Matters pertaining to directors, the BOD, committees, etc.

  • Appointment of the representative director
  • Appointment of the chairperson of the BOD
  • Approval of a director serving as a concurrent director at another company that competes with or operates in the same industry as the Samsung iologics and approval of transaction between a director, etc., and Samsung Biologics
  • Appoint or dismissal of a director from a specific position or duty

5. Others

  • Other matters set forth in the relevant laws and regulations or the AOI, authorized and delegatedby the general meeting of shareholders, or deemed necessary by the representative director

Activity of the BOD

Activity of the BOD includes the status of the board of directors' activities such as appointment, commissioning, approval, participation, decision, revision, enforcement, reporting and issuance.

2017

2017 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
JUL. 24, 2017 Report on financial results concerning 2Q/2017 - 5/5
1. Approval of transactions with major shareholders Approved
JUL. 30, 2017 Report on result of corporate appraisal of the company in the first half of 2017 - 5/5
MAY. 18, 2017 Report on status of operation of the company’s evaluation/remuneration system - 5/5
1. Approval of transactions with major shareholders Approved
APR. 25, 2017 Report on financial results concerning 1Q/2017 - 5/5
MAR. 24, 2017 1. Election of the representative director and entrustment of business to directors Approved 5/5
2. Appointment of the chairperson of the board of directors Approved
3. Appointment of members of the committees of the board of directors Approved
4. Execution of limit of directors’ remuneration Approved
5. Revision of the rules and regulations of the board of directors Approved
FEB. 27, 2017 1. Convening of the general meeting of shareholders and decision on purpose of the meeting Approved 5/5
2. Approval of transactions with major shareholders Approved
JAN. 24, 2017 1. Convening of the general meeting of shareholders and decision on purpose of the meeting Approved 5/5
JUL. 24, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 24, 2017 Attendance 5/5
Agenda Report on financial results concerning 2Q/2017
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
JUL. 30, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 30, 2017 Attendance 5/5
Agenda Report on result of corporate appraisal of the company in the first half of 2017
Result -
MAY. 18, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
MAY. 18, 2017 Attendance 5/5
Agenda Report on status of operation of the company’s evaluation/remuneration system
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
APR. 25, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 25, 2017 Attendance 5/5
Agenda Report on financial results concerning 1Q/2017
Result -
MAR. 24, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 24, 2017 Attendance 5/5
Agenda 1. Election of the representative director and entrustment of business to directors
Result Approved
Agenda 2. Appointment of the chairperson of the board of directors
Result Approved
Agenda 3. Appointment of members of the committees of the board of directors
Result Approved
Agenda 4. Execution of limit of directors’ remuneration
Result Approved
Agenda 5. Revision of the rules and regulations of the board of directors
Result Approved
FEB. 27, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 27, 2017 Attendance 5/5
Agenda 1. Convening of the general meeting of shareholders and decision on purpose of the meeting
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
JAN. 24, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 24, 2017 Attendance 5/5
Agenda 1. Convening of the general meeting of shareholders and decision on purpose of the meeting
Result Approved

2016

2016 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 13, 2016 1. Participation in Samsung Bioepis’ capital increase Approved 5/5
2. Participation in Archigen’s capital increase Approved
3. Approval of transactions with major shareholders Approved
4. Approval of transactions with specially related parties Approved
5. Subscription to retirement pension Approved
SEP. 29, 2016 1. Approval for issuance of new shares for IPO and for sales of old shares Approved 5/5
2. Approval of internal trading with specially related parties Approved
AUG. 10, 2016 1. Appointment of the chairperson of the board of directors Approved 5/5
2. Entrusting business to directors Approved
3. Appointment of the members of the committees of the board of directors Approved
4. Appointment of the compliance officer Approved
5. Appointment of the transfer agent Approved
DEC. 13, 2016 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 13, 2016 Attendance 5/5
Agenda 1. Participation in Samsung Bioepis’ capital increase
Result Approved
Agenda 2. Participation in Archigen’s capital increase
Result Approved
Agenda 3. Approval of transactions with major shareholders
Result Approved
Agenda 4. Approval of transactions with specially related parties
Result Approved
Agenda 5. Subscription to retirement pension
Result Approved
SEP. 29, 2016 Activity of the BOD - Date, Attendance, Agenda, Result,
SEP. 29, 2016 Attendance 5/5
Agenda 1. Approval for issuance of new shares for IPO and for sales of old shares
Result Approved
Agenda 2. Approval of internal trading with specially related parties
Result Approved
AUG. 10, 2016 Activity of the BOD - Date, Attendance, Agenda, Result,
AUG. 10, 2016 Attendance 5/5
Agenda 1. Appointment of the chairperson of the board of directors
Result Approved
Agenda 2. Entrusting business to directors
Result Approved
Agenda 3. Appointment of the members of the committees of the board of directors
Result Approved
Agenda 4. Appointment of the compliance officer
Result Approved
Agenda 5. Appointment of the transfer agent
Result Approved

SITE MAP

close
close

PRIVACY POLICY

초점받기 링크 PRIVACY STATEMENT OF SAMSUNG BIOLOGICS CO.LTD

Samsung Biologics (hereinafter, the “Company”) values users’ personal information, complies with statutory obligation s on protection of personal information such as the Act on Promotion of Information and Communication Network Utilization and Information Protection, etc. and the Act on Protection of Personal Information, and has created a Policy to Handle (Process) Personal Information to protect the users’ right and interest to the maximum extent possible.

Through the Policy to Handle (Process) Personal Information, the Company publicizes its operations on personal information treatment (processing) with particulars such as the types of personal information collected from the users and the purpose of processing such information, the time limit for processing and holding in possession, users’ method to exercise their rights, measures to procure the security, and so on.

Whenever there is a change in the Policy to Handle (Process) Personal Information, including updating, deleting, or adding its contents, whether resulting from any amendment to the relevant statutory sources or the administrative policy or change in the Company’s internal policy, we will post the change on our website at www.samsungbiologics. com so as to keep the users updated.

The Company’s Policy to Handle (Proce ss) Personal Information contains the following:

  • 1. Purpose of collecting and using personal information
  • 2. Types of personal information collected and method of collection
  • 3. Time limit for possessing and using personal information
  • 4. Matters regarding entrustment of personal information
  • 5. Matters on providing personal information to a third party
  • 6. Rights of users and legal representatives and how to exercise such rights
  • 7. Installation and operation of automatic collection of personal information and disallow ance
  • 8. Measures to procure security of personal information
  • 9. Personal information manager and customer complaint center
  • 10. Measures to remedy infringement of rights and interest
  • 11. Amendment to the Policy to Handle (Process) Personal Information
1.Purpose of collecting and using personal information

The Company collects personal information for the following purposes. The pfi will not be used for any other purpose and whenever it is necessary to change the purpose, we will comply with the statutory requirements such as obtaining users’ consents in advance.

  • Customer inquiry (Contact Us)

    Review and reply to the inquiries from users

  • Upload a curriculum vitae (Talent Pool Registration)

    Check employment history, give notices for future recruitment opportunities.

2.Types of personal information collected and method of collection
  • Types of personal information collected
    Collection Item information items include Category, Collection Item, and so on.
    Category Collection Item
    Contact Us,
    Talent Pool
    Required Name, Email Address, Company, Occupation, Country, Areas of Interest
    Optional Job Title, Phone Number

    The following information may be generated and collected in the course of using the service.

    Access long, cookie

  • Method to collect

    Collection through Contact Us, Talent Pool within the Website

    Collection through generated information collection tool (for access long, cookie, etc.)

3.Time limit for possessing and utilizing personal information
  • The time limit that the Company may possess and utilize personal information is as follows.

    Personal information that needs to be collected and utilized inevitably as specifically required by law or regulations, or in order to comply with statutory requirements : As long as it is necessary to keep such information in possession under relevant statute.

    Personal information that needs to be collected and utilized inevitably in order to execute and perform various contracts: Until the purpose of collection/utilization is accomplished.

    Personal information collected and used with the consent of individual user: For the time period consented to.

  • Once time period for possession and utilization of the collected personal informationexpires or the purpose is accomplished, the Company will immediately destroy the personal information. However, the Company may continue to possess it beyond the time limit if deemed necessary under the
4.Entrustment of personal information
  • If, in order to provide better service, it is desirable to entrust the handling of personal information to an independent professional business, the Company will obtain the consent of the owner of information and notify the name of the trustee company and the service to be entrusted.
  • When entrusting personal information processing, the Company will ensure to safeguard the personal information. In particular, we will clearly define in the contract such matters as strict compliance with instructions for personal information protection, keeping the personal information confidential, prohibition of disclosing the personal information to a third party, liability attribution at an accident, entrustment period, return or destruction of personal information after the completion of the processing, which will be recorded in paper and/or electronic media.
  • In case of any change in the service contents or in the trustee, we will immediately disclose such change via this Policy to Handle (Process) Personal Information
5.Matters on providing personal information to a third party
  • The Company will not disclose duly collected users’ personal information outside the Company as a matter of principle. However, as follows are the exceptions.

    If the user has given his/her consent in advance.

    If it is specifically required by laws or regulations or inevitable in order to comply with statutory requirements, or if it is deemed necessary for the sake of life, body or property of the information owner or a third party when the information owner or his/her legal representative is under a state incapable of communication or unable to give consent due to unknown domiciles or otherwise (only to the extent the purpose of collecting personal information is served).

  • A user has right to disallow disclosure of his/her personal information to a third party. However, those users who refuse to give consents may have his/her use of the service limited.
6.Rights of users and legal representatives and how to exercise such rights
  • Any user (or his/her legal representative) may withdraw the consent to collection, utilization and conveyance of personal information at any time and may also demand that the following information be tendered for viewing corrected, deleted, or suspended processing, in accordance as prescribed in laws or decrees. Once demanded by a user (or his/her legal representative), the Company will immediately take the appropriate actions, as long as such demand is reasonable and well-grounded.

    User’s personal information

    History of the users personal information being utilized or provided to a third party

    History of consents given to collection, utilization and provision of personal information

  • In any of the following cases, the Company may restrict or refuse to allow access to, tender, correct, delete or suspend processing personal information upon notifying user (or his/her legal representative) of the reason.

    If it is specifically required by laws or regulations or inevitable in order to comply with statutory requirements.

    If it is likely to jeopardize a person’s life or body or unjustly infringe a person’s property or other interests.

  • When the Company decides not to honor a user (or his/her legal representative) demand, we will advise him/her of the fact, reason and process to object the decision in accordance as prescribed in the laws and decrees.
7.Installation and operation of automatic collection of personal information and disallowance

The Company is operating cookies that regularly stores and locates users’ information.

  • Purpose of operating cookies The purpose of the cookie operation is to provide users with optimized information based on the data of users’ website visit and utilization as well as the number of users.
  • Cookie creation, confirmation and how to disallow Each user has the option to allow or disallow cookie installation. By setting an option on the web browser, a user may allow all the cookies, give confirmation every time a cookie is stored, or disallow any cookie storage. However, refusing to allow installation of cookies may lead to some limitation of service to the user.

    How to install cookies (if using Internet explorer 8.0) Select “Internet Option” in the “Tool”. Click “Privacy” tab. Using “Setting”, users may set the level of allowing cookies as suitable for their own needs.

    How to view the cookie received (if using Internet explorer 8.0)

    Select “Internet Option” in the “Tool”. Click “General” tab and select “Setting” of the Browsing History to check the files in “View Files”.

    How to disallow cookie installation (if using Internet explorer 8.0) Select “Internet Option” in the “Tool”. Click “Privacy” tab. Using “Setting”, set it to the higher level, that is, “Block All Cookies”

8.Measures to procure security of personal information

in handling users’personal information, the Company endeavors to keep the personal information from being lost, stolen, revealed, tampered or damaged. To this end, the following technical and managerial actions are taken.

  • Establishment and implementation of internal management plan

    The Company implements its own internal management plan to secure safety in processing the personal information.

    The Company is operating an internal organization dedicated to personal information protection to monitor the status of compliance with the personal information protective requirements and the responsible staff’s duty performance and takes corrective measures when any irregularity is found.

  • Restriction of access to personal information

    Installation and operation of access restriction device Using the intrusion blocking system, the Company controls any unauthorized access from outside and endeavors to procure all the technological system to the maximum extent feasible in order to secure systematic security.

    Minimized designation of personal information processors and education The Company minimizes designation of personal information processors and implements internal and/or outsourced education on a regular basis. Personal information processors’ duty handover is conducted with the security fully maintained and their responsibilities for any personal information accident are clearly defined even after they have left the Company.

    Restrictions on access to personal information The Company places restrictions on access to personal information through granting, changing or revoking the right to access to database system that processes personal information. We also record the history of granting, changing or revoking the right, which are retained for our records for at least three years.

  • Encryption of personal information

    The personal information of users is protected by the password and the file and transmission data are encrypted or stored by using file lock function. More important data are protected through certain separate security measures.

    The Company has adopted security devices that enable safe transmission of personal information on the network using encryption algorithm.

  • Installation and updating of security program

    To safeguard personal information from leak or loss by hackers or computer viruses, the Company has installed a security program and conducts periodic updating and reviewing.

    For unmistakable security operation, every server is installed with intrusion blocking system as a means to block outsider intrusion by hacking as well as a system to analyze vulnerability.

9.Personal information manager and customer complaint center

To protect users’personal information and handle personal information-related customer complaint, the Company has appointed a personal information manager and processor. Any inquiry related to personal information protection and management should be directed to the personal information processor for instant and adequate reply.

  • personal information management (protection) processor

    Division: General Affairs Security Part, Personnel Management Team

    Contact: 032-455-3739

    E-mail: bio.security@samsung.com

10.Measures to remedy infringement of rights and interest

Any user seeking to relief from personal information infringement may apply for resolution or consultation to Personal Information Dispute Mediation Committee, Korea Internet and Security Agency (Personal Information Grievance Center). In addition, users may contact the following institutions to be consulted on personal information infringement cases.

  • Personal Information Dispute Mediation Committee (118)

    Korea Internet and Security Agency (Personal Information Grievance Center)(www.kopico.or.kr/1336)
    Information Protection Mark Verification Committee (http://eprivacy.or.kr/02-580-0533~4)
    Internet Crime Investigation Center of the Supreme Prosecutors’ Office
    (http://icic.sppo.go.kr/02-3480-3600)
    Cyber Police Agency (www.police.go.kr/1566-0112)
    Personal information Protection Committee (http://privacy.kisa.or.kr/kor/main.jsp)/02-2180-3000)

11.Amendment to the Policy to Handle (Process) Personal Information

When this ‘Policy to Handle (Process) Personal Information’ needs to be changed to reflect the change in statutory sources or government policies, we will put such change in public notice through an advisory statement and a separate window on the website.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION